---
figid: PMC9585928__d2ra05751d-f1
pmcid: PMC9585928
image_filename: d2ra05751d-f1.jpg
figure_link: /pmc/articles/PMC9585928/figure/fig1/
number: Fig. 1
figure_title: '(a) Normal and oncogenic BRAF signaling pathway notes: normal activation
  of RAS-RAF pathway shows normal cell proliferation and survival. Oncogenic BRAF
  signaling causes an increase in cell proliferation and survival from benign nevus
  to metastatic melanoma (b) V600E mutation in BRAF protein structure (c) BRAF inhibitor
  binding mode with conformations (αC-helix and DFG motif)'
caption: '(a) Normal and oncogenic BRAF signaling pathway notes: normal activation
  of RAS-RAF pathway shows normal cell proliferation and survival. Oncogenic BRAF
  signaling causes an increase in cell proliferation and survival from benign nevus
  to metastatic melanoma (b) V600E mutation in BRAF protein structure (c) BRAF inhibitor
  binding mode with conformations (αC-helix and DFG motif).'
article_title: Gaussian field-based 3D-QSAR and molecular simulation studies to design
  potent pyrimidine–sulfonamide hybrids as selective BRAFV600E inhibitors.
citation: Ankit Kumar Singh, et al. RSC Adv. 2022 Oct 17;12(46):30181-30200.
year: '2022'

doi: 10.1039/d2ra05751d
journal_title: RSC Advances
journal_nlm_ta: RSC Adv
publisher_name: The Royal Society of Chemistry

keywords:
---
